Yüklüyor......
Indications for 5-aminosalicylate in inflammatory bowel disease: Is the body of evidence complete?
Mesalazine is a safe drug, although adverse events may be seen in a minority of patients. This applies also to pregnant women and children. The role of mesalazine in combination therapy to improve efficacy and concomitant drug pharmacokinetics, or in chemoprevention against inflammatory bowel diseas...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Co., Limited
2006
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4088103/ https://ncbi.nlm.nih.gov/pubmed/17036381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i38.6115 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|